Goodwin’s 2025 Rare Disease Symposium, held on February 5 in Boston and virtually, gathered patient advocates and caregivers, providers, researchers, biotech and medtech leaders, investors, and policy experts to discuss the...more
The COVID-19 outbreak inevitability has spurred unprecedented progress on a paradigm shift to telemedicine. According to a recent study by the Boston Consulting Group, China is already the world’s third largest Med Tech...more